Big biotech United Therapeutics (UTHR) agreed to sell its priority-review voucher to AbbVie (ABBV) for $350 million, giving United an infusion of cash and AbbVie a chance to speed up the FDA approval of one of its drugs. United gained the Rare Pediatric Disease Priority Review Voucher (PPRV) upon the March 10 approval of Unituxin, a treatment for a rare childhood cancer called neuroblastoma. The FDA started the PPRV program to encourage the
Sprint (S) has gained marketing momentum, says Pacific Crest Securities, which forecasts that wireless industry promotional activity might pick up during the back-to-school shopping period. While some Wall Street analysts have recently said aggressive discounting appeared to be easing, perhaps until the Q4 holiday shopping season, others say Apple’s (AAPL) expected rollout of the iPhone 6S in mid-September could bring a new round of price cutting.
Facing increased competition and slower sales growth, China’s largest Internet companies are spending billions to ramp up a business strategy known as online to offline, or O2O, retailing. Online to offline is expected to figure heavily in the future of retailing and consumption in China. It’s seen as a better way for China consumers to research and buy goods, and receive them quickly, with smartphones playing a key role through search and payment